Help us fight preventable vision loss.

Retina Technologies’ game-changing platform is ready to revolutionize the $5.3 billion eye exam market—now is your chance to invest.

By developing OcuVue™ to run in under 15 minutes with a better user experience, at a fraction of the cost and footprint — we’re on a mission to bring together primary care and vision specialists to reduce needless vision loss around the globe.

Join us in making OcuVue™ the trusted standard for vision screening—from the remotest region to the largest health care enterprise.

Reasons to Invest

• Backed by Leading Investors and Professionals: Raised a total of $333K to date from grants and investor groups including Harvard Business Alumni Angels, and established strategic partnerships with premier practices, including the Mount Sinai Health System and its ophthalmic branch, the New York Eye and Ear Infirmary.

• Experienced Team in Developing and Launching Digital Technologies for Enterprise and Healthcare Environments: OcuVue™ has been designed with feedback from 100+ healthcare professionals and potential customers. Our platform is being developed by a team with decades of experience in global go-to-market, large healthcare integration and workflows, and vision care.

• Billion-Dollar Vision Market Ready for Digital Transformation: The global ophthalmology diagnostic tools market is worth $2.7 billion and growing at a CAGR of 5.4%. The U.S. eye examination market is currently worth more than $5 billion. (Source)

Questions about equity crowdfunding? Learn about investing in startups online by visiting: ”Investing in Startups with StartEngine”